Primary Non-metastatic Breast Cancer
.Primary Non-Metastatic Breast Cancer
Primary non-metastatic breast cancer is a type of cancer that has not spread beyond the breast tissue. This means that the cells in the tumor are contained within the breast and have not spread to other parts of the body. It is one of the most common types of cancer, with over 200,000 new cases in the United States each year.
Treatment for this type of cancer focuses on removing the cancerous tumor from the body. The exact methods used will depend on the stage of the cancer and the patient’s overall health. Common treatments include breast-conserving surgery, mastectomy, radiation therapy, chemotherapy, hormone therapy, and targeted therapy.
The prognosis for primary non-metastatic breast cancer is generally good. The survival rate for this type of cancer is much higher than it is for metastatic cancer, which has spread to other parts of the body. With proper treatment, many people with primary non-metastatic breast cancer can lead full, active lives.
Risk factors
There are several risk factors for primary non-metastatic breast cancer, including:
- Age: Women over the age of 50 are more likely to develop breast cancer than younger women.
- Family history: Women with a family history of breast cancer are at increased risk.
- Being overweight: Women who are overweight or obese are at a higher risk of breast cancer.
- Hormone replacement therapy: Women who take hormone replacement therapy after menopause may be more likely to develop breast cancer.
- Alcohol consumption: Women who drink alcohol regularly or excessively are at an increased risk.
Prevention
While there is no sure way to prevent primary non-metastatic breast cancer, there are steps people can take to reduce their risk. These include:
- Maintaining a healthy weight.
- Limiting alcohol consumption.
- Avoiding hormone replacement therapy unless medically necessary.
- Regularly performing breast self-exams and scheduling annual mammograms.
By following these steps, people can reduce their risk of developing primary non-metastatic breast cancer and increase their chances of successful treatment outcomes.